Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
108,743,491
-
Share change
-
+2,522,011
-
Total reported value
-
$1,978,272,193
-
Put/Call ratio
-
113%
-
Price per share
-
$18.20
-
Number of holders
-
291
-
Value change
-
+$47,411,066
-
Number of buys
-
109
-
Number of sells
-
136
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2020
As of 31 Dec 2020,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
291 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,743,491 shares.
The largest 10 holders included
GLENVIEW CAPITAL MANAGEMENT, LLC, PAULSON & CO. INC., ARK Investment Management LLC, Adelphi Capital LLP, RENAISSANCE TECHNOLOGIES LLC, PRICE T ROWE ASSOCIATES INC /MD/, NORTHERN TRUST CORP, MACQUARIE GROUP LTD, Parametric Portfolio Associates LLC, and Mondrian Investment Partners LTD.
This page lists
291
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.